CNBC's Meg Tirrell digs into the friendly and hostile M&A action taking place in pharmaceuticals, including a deal between Novartis and GlaxoSmithKline, and Valeant Pharmaceuticals bid for Allergan.» Read More
Citi investors are in St. Louis today for the bank's annual shareholder meeting. CNBC's Kayla Tausche provides insight into the day's schedule.
The megabillion-dollar deals with Novartis also allow GlaxoSmithKline to "significantly expand" its world-leading vaccine business, GSK's CEO tells CNBC.
Valeant Pharmaceuticals offered $48.30 share cash, as well as 0.83 shares for Allergan. CNBC's Meg Tirrell provides insight.
McDonald's is reporting Q1 EPS of $1.21 on revenue of $6.700 billion, with the "Squawk Box" crew.
Chris Baggini of Turner Titan Fund, explains his top three stock picks for investors right now. He says Facebook's advertising model is "very strong."
BTIG media and tech analyst Rich Greenfield, questions why some of the bandwidth burden should or shouldn't fall on Netflix.
Comcast reported $0.68 ex-items on revenue of $17.408 billion in Q1. BTIG media and tech analyst Rich Greenfield, discusses cable network advertising, and explains the opportunities that could arise from the Time Warner Cable and Comcast deal.
Eli Lilly Chairman & CEO John Lechleiter discusses his business' expansion of its animal health unit with the acquisition of Novartis' animal health business.
Discussing current market conditions, and how the activist investor is changing the conversation in the board room, with Julian Emanuel, UBS, and Charles Kantor, Neuberger Berman.
In an SEC Filing, Valeant Pharmaceuticals said it expected to offer a mix of stock and about $15 billion in cash for botox maker Allergan. David Krempa, Morningstar equity analyst, and CNBC's Meg Tirrell, provide perspective.
Comcast is reporting $0.68 ex-items on revenue of $17.408 billion, with the "Squawk Box" crew.
GlaxoSmithKline CEO Sir Andrew Witty, explains the large portfolio of vaccinations his company provides, and the value added from the company's acquisition of Novartis' vaccination business.
GlaxoSmithKline CEO Sir Andrew Witty, discusses the benefit to shareholders from his company's acquisition of Novartis' vaccination business, as well as its oncology unit.
Dissecting current market action, and the building M&A cycle, with Mary Ann Bartels, Merrill Lynch Wealth Management. "We think capex will be the next step for investing," she explains.
Yale School of Management senior associate dean Jeff Sonnenfeld, says Mark Fields has become a "genuine car guy," in discussing reports Mark Fields will take over as CEO at Ford.
Netflix's Q1 earnings beat the Street's expectations. Will Power, Robert Baird senior research analyst, anticipates growth in the company for years. "The real story is international for Netflix," he says.
Netflix announced it intends to raise its membership price for new subscribers, and Netflix CEO Reed Hastings remarked on the proposed Comcast and Time Warner Cable deal during the webcast, with the "Squawk Box" crew.
The S&P 500 should deliver a double-digit return in 2014, fund manager Ed Keon told CNBC. And the low on April 11 has a "pretty good chance" of being the recent bottom, he added.
Fred Davis, Arista Advisors CEO, discusses his plans to finance tech startups in Silicon Valley.
CNBC's Scott Cohn talks with Boston Mayor Martin Walsh about the security challenges surrounding this year's marathon.
Get the best of CNBC in your inbox
Joe Kernen is co-anchor of "Squawk Box," CNBC's signature morning program.
Becky Quick is co-anchor of "Squawk Box," CNBC's signature morning program. She's also a columnist for Fortune.
Andrew Ross Sorkin is a co-anchor of "Squawk Box," a financial columnist for "The New York Times" and the editor-at-large of NYT's DealBook.